Sergei Aleksandrovich Afanasiev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sergei Aleksandrovich Afanasiev has a total of 231 co-authors. Here are the top co-authors by number of shared publications:
- Elvira Faritovna Muslimova
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (Cardiology Research Institute, Tomsk NRMC)
34 shared publications - Tatiana Yurievna Rebrova
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (Cardiology Research Institute, Tomsk NRMC)
34 shared publications - Sergey Valentinovich Popov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kievskaya St., 111a, Tomsk 634012, Russia
21 shared publications - Vyacheslav Andreevich Korepanov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (Cardiology Research Institute, Tomsk NRMC)
15 shared publications - Roman Efimovich Batalov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kievskaya St., 111a, Tomsk 634012, Russia
14 shared publications - Dina S. Kondratyeva
Cardiology Research Institute, Tomsk National Research Medical Center (Cardiology Research Institute, Tomsk NRMC), Russian Academy of Sciences
10 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9912
Erythrocyte Membrane β-Adrenoreactivity as a Systemic Adrenergic Phenotype Associated with Ventricular Tachyarrhythmia in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy
Chronic hyperactivity of the sympathetic nervous system and remodeling of β-adrenergic receptors represent core pathophysiological mechanisms in heart failure with reduced ejection fraction (HFrEF) and in the emergence of ventricular arrhythmias. Nevertheless, clinically applicable functional indicators of this axis are still limited. We investigated whether erythrocyte membrane β-adrenoreactivity (EMA), an indirect functional membrane index derived from β-adrenergic antagonist-modulated hypo-osmotic hemolysis, correlates with a ventricular tachyarrhythmia (VTA) phenotype following cardiac resynchronization therapy with defibrillation capability (CRT-D). In a single-center observational cohort, 99 HFrEF patients underwent CRT-D implantation. A total of 70 patients with complete baseline and 12-month data formed the complete-case analysis (NCT03667989: n = 14; NCT05769036: n = 36; non-registry enrollment under the same institutional protocol: n = 20). Patients were categorized by the prespecified database variable “VTA preCRT and 12 m. post-CRT” into VTA-positive (n = 38) and VTA-negative (n = 32) groups. Baseline EMA was higher in VTA-positive patients (31.4% [22.8; 48.3]) than in VTA-negative patients (22.0% [15.8; 33.4]; p = 0.012). In multivariate logistic regression with stepwise selection, two variables were independently associated with the VTA-positive phenotype: EMA (odds ratio [OR] = 1.0446 per 1%; 95% confidence interval [CI] 1.0092–1.0812; p = 0.013) and left ventricular end-systolic dimension (LVESD) (OR = 1.1023 per 1 mm; 95% CI 1.0102–1.2029; p = 0.029). The model was statistically significant (likelihood-ratio χ2 = 12.567; p = 0.0019) and well calibrated (Hosmer–Lemeshow χ2 = 9.70; p = 0.286), with good discrimination (AUC = 0.748; 95% CI 0.629–0.844). However, explanatory power was modest (Nagelkerke R2 = 0.220), indicating that most variance in the VTA phenotype remains unexplained by EMA and LVESD. At a cut-off of 0.5, sensitivity was 73.68%, specificity 71.87%, and overall accuracy 72.86%. Internal validation with 2000 bootstrap iterations confirmed robustness (optimism-corrected AUC = 0.727; 95% CI 0.612–0.835). EMA remained significant after adjustment for LVESD, supporting its role as an independent marker of the VTA-positive phenotype. The model outperformed all univariate models in terms of AUC, R2, and overall accuracy. EMA may therefore be associated with a systemic adrenergic membrane phenotype and an arrhythmic substrate. These findings require mechanistic validation and external replication before any clinical application. All reported cut-offs are exploratory and derived from a single center, and the analysis is based on a complete-case cohort with acknowledged potential for attrition bias.
- 5 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9912
Open AccessErythrocyte Membrane β-Adrenoreactivity as a Systemic Adrenergic Phenotype Associated with Ventricular Tachyarrhythmia in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy
Chronic hyperactivity of the sympathetic nervous system and remodeling of β-adrenergic receptors represent core pathophysiological mechanisms in heart failure with reduced ejection fraction (HFrEF) and in the emergence of ventricular arrhythmias. Nevertheless, clinically applicable functional indicators of this axis are still limited. We investigated whether erythrocyte membrane β-adrenoreactivity (EMA), an indirect functional membrane index derived from β-adrenergic antagonist-modulated hypo-osmotic hemolysis, correlates with a ventricular tachyarrhythmia (VTA) phenotype following cardiac resynchronization therapy with defibrillation capability (CRT-D). In a single-center observational cohort, 99 HFrEF patients underwent CRT-D implantation. A total of 70 patients with complete baseline and 12-month data formed the complete-case analysis (NCT03667989: n = 14; NCT05769036: n = 36; non-registry enrollment under the same institutional protocol: n = 20). Patients were categorized by the prespecified database variable “VTA preCRT and 12 m. post-CRT” into VTA-positive (n = 38) and VTA-negative (n = 32) groups. Baseline EMA was higher in VTA-positive patients (31.4% [22.8; 48.3]) than in VTA-negative patients (22.0% [15.8; 33.4]; p = 0.012). In multivariate logistic regression with stepwise selection, two variables were independently associated with the VTA-positive phenotype: EMA (odds ratio [OR] = 1.0446 per 1%; 95% confidence interval [CI] 1.0092–1.0812; p = 0.013) and left ventricular end-systolic dimension (LVESD) (OR = 1.1023 per 1 mm; 95% CI 1.0102–1.2029; p = 0.029). The model was statistically significant (likelihood-ratio χ2 = 12.567; p = 0.0019) and well calibrated (Hosmer–Lemeshow χ2 = 9.70; p = 0.286), with good discrimination (AUC = 0.748; 95% CI 0.629–0.844). However, explanatory power was modest (Nagelkerke R2 = 0.220), indicating that most variance in the VTA phenotype remains unexplained by EMA and LVESD. At a cut-off of 0.5, sensitivity was 73.68%, specificity 71.87%, and overall accuracy 72.86%. Internal validation with 2000 bootstrap iterations confirmed robustness (optimism-corrected AUC = 0.727; 95% CI 0.612–0.835). EMA remained significant after adjustment for LVESD, supporting its role as an independent marker of the VTA-positive phenotype. The model outperformed all univariate models in terms of AUC, R2, and overall accuracy. EMA may therefore be associated with a systemic adrenergic membrane phenotype and an arrhythmic substrate. These findings require mechanistic validation and external replication before any clinical application. All reported cut-offs are exploratory and derived from a single center, and the analysis is based on a complete-case cohort with acknowledged potential for attrition bias.
- Open Access
- 13 October 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
Beta-adrenergic receptors expression in cardiomyocytes with structural and functional myocardial changes in patients with chronic heart failure with preserved ejection fraction
Introduction. Chronic hypersympathicotonia, excessive stimulation of beta-adrenergic receptors (beta-ARs) are key drivers of myocardial remodeling in chronic heart failure (CHF). Beta1-ARs desensitization is a compensatory mechanism limiting catecholamines damaging effects, but its progression exacerbates contractile dysfunction. Beta2-ARs exert predominantly protective effects, attenuating the cardiotoxicity of chronic catecholamine exposure. Of particular interest is the study of these processes in CHF with preserved ejection fraction (HFpEF) in the absence of myocardial infarction, rhythm disturbances, or valvular defects. Aim: To evaluate ADRB1 , ADRB2 genes expression levels and beta1-, beta2-adrenergic receptors myocardial content in HFpEF depending on the presence of structural, functional changes in the myocardium. Material and Methods. A total of 115 patients (65±6.9 years) with coronary artery disease, hypertension, HFpEF were included. ADRB1 , ADRB2 expression (digital droplet PCR), beta1-, beta2-AR levels (ELISA) were determined in right atrial appendage biopsies. Erythrocyte membranes beta-adrenergic reactivity (beta-ARM) was assessed in the blood. Results. Beta-ARM didn't differ between CHF functional classes, in patients with left ventricular (LV) hypertrophy, left atrial (LA) dilation, diastolic dysfunction and without them. With LA dilation, a significant decrease in beta1-AR levels was revealed (2.89 (1.91; 3.75) vs 3.54 (2.88; 4.82) ng/mg protein, p=0.014) with unchanged ADRB1 expression. A direct correlation was established between beta2-AR and end systolic (r=0.363, p=0.045), diastolic volumes (r=0.424, p=0.017), but ADRB2 , beta2-AR levels didn’t depend on the presence of LV hypertrophy or LA dilation. In obesity, beta1-AR higher level was recorded (3.82 (2.89; 4.54) vs 3.25 (2.27; 3.65), p=0.028), in diabetes mellitus 2, the ADRB2 expression was increased (0.017 (0.010; 0.036) vs 0.009 (0.006; 0.013), p=0.005). Conclusion. In patients with HFpEF without myocardial infarction, structural, functional myocardial changes weren’t accompanied by a significant increase in beta-ARM. Decreased beta1-AR level in cardiomyocytes are characteristic of LA dilation, but elevated beta2-AR correlated with increased LV volumes. Obesity was associated with higher beta1-AR level; diabetes mellitus was associated with increased ADRB2 gene expression. The CHF phenotype under study is characterized by a localized pattern of adrenergic dysregulation and divergent changes in the levels of beta-AR subtypes in cardiomyocytes, which are significantly influenced by metabolic disorders.
- 13 October 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
Open AccessBeta-adrenergic receptors expression in cardiomyocytes with structural and functional myocardial changes in patients with chronic heart failure with preserved ejection fraction
Introduction. Chronic hypersympathicotonia, excessive stimulation of beta-adrenergic receptors (beta-ARs) are key drivers of myocardial remodeling in chronic heart failure (CHF). Beta1-ARs desensitization is a compensatory mechanism limiting catecholamines damaging effects, but its progression exacerbates contractile dysfunction. Beta2-ARs exert predominantly protective effects, attenuating the cardiotoxicity of chronic catecholamine exposure. Of particular interest is the study of these processes in CHF with preserved ejection fraction (HFpEF) in the absence of myocardial infarction, rhythm disturbances, or valvular defects. Aim: To evaluate ADRB1 , ADRB2 genes expression levels and beta1-, beta2-adrenergic receptors myocardial content in HFpEF depending on the presence of structural, functional changes in the myocardium. Material and Methods. A total of 115 patients (65±6.9 years) with coronary artery disease, hypertension, HFpEF were included. ADRB1 , ADRB2 expression (digital droplet PCR), beta1-, beta2-AR levels (ELISA) were determined in right atrial appendage biopsies. Erythrocyte membranes beta-adrenergic reactivity (beta-ARM) was assessed in the blood. Results. Beta-ARM didn't differ between CHF functional classes, in patients with left ventricular (LV) hypertrophy, left atrial (LA) dilation, diastolic dysfunction and without them. With LA dilation, a significant decrease in beta1-AR levels was revealed (2.89 (1.91; 3.75) vs 3.54 (2.88; 4.82) ng/mg protein, p=0.014) with unchanged ADRB1 expression. A direct correlation was established between beta2-AR and end systolic (r=0.363, p=0.045), diastolic volumes (r=0.424, p=0.017), but ADRB2 , beta2-AR levels didn’t depend on the presence of LV hypertrophy or LA dilation. In obesity, beta1-AR higher level was recorded (3.82 (2.89; 4.54) vs 3.25 (2.27; 3.65), p=0.028), in diabetes mellitus 2, the ADRB2 expression was increased (0.017 (0.010; 0.036) vs 0.009 (0.006; 0.013), p=0.005). Conclusion. In patients with HFpEF without myocardial infarction, structural, functional myocardial changes weren’t accompanied by a significant increase in beta-ARM. Decreased beta1-AR level in cardiomyocytes are characteristic of LA dilation, but elevated beta2-AR correlated with increased LV volumes. Obesity was associated with higher beta1-AR level; diabetes mellitus was associated with increased ADRB2 gene expression. The CHF phenotype under study is characterized by a localized pattern of adrenergic dysregulation and divergent changes in the levels of beta-AR subtypes in cardiomyocytes, which are significantly influenced by metabolic disorders.
- Open Access
- 1 October 2026
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 25 (3) , 5-10
Heterogeneity of Human Cardiac Muscle Inotropic Response to Stimulation of β1-adrenergic Receptors and Their Expression in Chronic Coronary Heart Disease
Aim. To study the intensity and correlation between the inotropic responses of myocardium in patients with chronic coronary heart disease (CHD) upon stimulation of β1-adrenergic receptors (β1-AR) and the expression levels of these receptors in cardiomyocytes. Materials and methods. Isolated myocardium (fragment of the right atrial appendage) from 46 patients with chronic CHD was obtained during coronary artery bypass grafting. The inotropic response of muscle strips was evaluated in an isometric condition. To affect β1-adrenergic receptors (β1-ARs), norepinephrine (10 –7 M) was used under pre-blockade of α-adrenergic receptors (α-AR). The expression of β1-ARs was determined by Western blotting in the same myocardial samples. Results. It has been established that the myocardium of this cohort of CHD patients demonstrated significant heterogeneity both in terms of the inotropic response to stimulation of β1-adrenergic receptors and the degree of their receptor expression. A significant positive correlation ( r = 0.72; p < 0.001) was observed between the inotropic response of muscle strips and the expression level of β1-ARs in these patients’ myocardium. Conclusion. These findings confirm that the extent of the inotropic response of the myocardium to activation of β1-ARs significantly depends on the number of β1-ARs present when chronic CHD develops. This dependency reflects the degree of cardiac remodeling occurring in this pathology.
- 1 October 2026
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 25 (3) , 5-10
Open AccessHeterogeneity of Human Cardiac Muscle Inotropic Response to Stimulation of β1-adrenergic Receptors and Their Expression in Chronic Coronary Heart Disease
Aim. To study the intensity and correlation between the inotropic responses of myocardium in patients with chronic coronary heart disease (CHD) upon stimulation of β1-adrenergic receptors (β1-AR) and the expression levels of these receptors in cardiomyocytes. Materials and methods. Isolated myocardium (fragment of the right atrial appendage) from 46 patients with chronic CHD was obtained during coronary artery bypass grafting. The inotropic response of muscle strips was evaluated in an isometric condition. To affect β1-adrenergic receptors (β1-ARs), norepinephrine (10 –7 M) was used under pre-blockade of α-adrenergic receptors (α-AR). The expression of β1-ARs was determined by Western blotting in the same myocardial samples. Results. It has been established that the myocardium of this cohort of CHD patients demonstrated significant heterogeneity both in terms of the inotropic response to stimulation of β1-adrenergic receptors and the degree of their receptor expression. A significant positive correlation ( r = 0.72; p < 0.001) was observed between the inotropic response of muscle strips and the expression level of β1-ARs in these patients’ myocardium. Conclusion. These findings confirm that the extent of the inotropic response of the myocardium to activation of β1-ARs significantly depends on the number of β1-ARs present when chronic CHD develops. This dependency reflects the degree of cardiac remodeling occurring in this pathology.
- Open Access
- 4 September 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (4) , 6-21
ASSOCIATION OF THE T1565C (RS5918) POLYMORPHISM IN THE INTEGRINE-Β3 (ITGB3) GENE WITH INTERVENTION CHARACTERISTICS, PERIPROCEDURAL COMPLICATIONS, AND LONG-TERM PROGNOSIS AFTER PLANNED ENDOVASCULAR MYOCARDIAL REVASCULARIZATION Running title: ITGB3 polymorphism: interventions, complications, and prognosis
Highlights Polymorphism rs5918 in the ITGB3 gene is associated with procedural features, acute complications and long-term prognosis after elective endovascular myocardial revascularization. In the group of patients with stable coronary artery disease who have indications for elective PCI, the presence of the T allele is associated with concomitant carbohydrate metabolism disorders, multivessel coronary artery disease, implantation of 2 or more stents, and a lower rate of achieving complete myocardial revascularization during index PCI. The presence of the minor allele C and the homozygous genotype CC is associated with greater comorbidity in patients, features of coronary atherosclerosis in the form of more frequent hemodynamically significant lesions of the left main coronary artery and anterior descending artery, more frequent achievement of complete myocardial revascularization and a lower value of the residual SYNTAX index with the implantation of a smaller number of stents during the index intervention. In the recessive model (TT + TC/CC), the presence of the minor homozygous CC genotype increased the odds of developing periprocedural AKI by 7.2 times (OR 7.200; 95% CI [1.827–28.379], p = 0.011). Five years after the index PCI, patients with the minor C allele had worse renal function than those with the T allele (GFR ≤ 60 ml/min/1.73 m 2 in 19%, 36%, and 40% of patients in the groups with the TT, TC, and CC genotypes, respectively, p = 0.04). Aim. To study the association of the T1565C (rs5918) polymorphism in the ITGB3 gene with the characteristics of interventions, periprocedural complications and long-term prognosis of patients after elective endovascular myocardial revascularization. Methods . Polymorphic variants of the single nucleotide polymorphism T1565C (rs5918) in the ITGB3 gene were identified in 364 patients undergoing elective PCI. We studied the characteristics of coronary artery disease and the interventions performed, and also assessed the frequency of acute complications, late (5-year) adverse events, and the dynamics of renal function in the acute and late periods in groups of patients with different genotypes of the rs5918 polymorphism in the ITGB3 gene. Contingency tables and odds ratio (OR) calculations were used to assess the association of this polymorphism with endpoints. Results . The minor allele 1565C and the 1565CC of the polymorphism T1565C (rs5918) in the ITGB3 gene genotype are associated with more frequent hemodynamically significant stenosis of the left main coronary artery (4.4, 6.9 and 30% in the TT, TC and CC groups, respectively, p = 0.003) and the anterior descending artery (79, 66.7 and 100% in the TT, TC and CC groups, respectively, p = 0.01), more frequent achievement of complete myocardial revascularization (54.4, 70.6, 70% in the TT, TC and CC groups, respectively, p = 0.01) and a lower residual SYNTAX index (4.1 ± 6.7 (0–43.5); 2.9 ± 6.2 (0–28.5) and 2.4 ± 4.6 (0–14) in the TT, TC and CC groups, respectively, p = 0.02) with implantation of a smaller number of stents. In addition, an association was found between the minor 1565CC genotype with acute periprocedural kidney injury (OR 7.200; 95% CI [1.827–28.379], p = 0.011) and deterioration of renal function 5 years after index PCI (SCF ≤ 60 ml/min/1.73 m 2 in 19, 36 and 40% in the TT, TC and CC groups, respectively, p = 0.04). Conclusion . Under conditions of dual antiplatelet therapy, selected taking into account the residual platelet reactivity according to the aggregogram data, no association was found between the T1565C (rs5918) polymorphism in the ITGB3 gene and acute periprocedural myocardial injury and long-term cardiovascular complications. Polymorphism rs5918 in the ITGB3 gene is associated with acute periprocedural kidney injury and decreased renal function in the late period.
- 4 September 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (4) , 6-21
Open AccessASSOCIATION OF THE T1565C (RS5918) POLYMORPHISM IN THE INTEGRINE-Β3 (ITGB3) GENE WITH INTERVENTION CHARACTERISTICS, PERIPROCEDURAL COMPLICATIONS, AND LONG-TERM PROGNOSIS AFTER PLANNED ENDOVASCULAR MYOCARDIAL REVASCULARIZATION Running title: ITGB3 polymorphism: interventions, complications, and prognosis
Highlights Polymorphism rs5918 in the ITGB3 gene is associated with procedural features, acute complications and long-term prognosis after elective endovascular myocardial revascularization. In the group of patients with stable coronary artery disease who have indications for elective PCI, the presence of the T allele is associated with concomitant carbohydrate metabolism disorders, multivessel coronary artery disease, implantation of 2 or more stents, and a lower rate of achieving complete myocardial revascularization during index PCI. The presence of the minor allele C and the homozygous genotype CC is associated with greater comorbidity in patients, features of coronary atherosclerosis in the form of more frequent hemodynamically significant lesions of the left main coronary artery and anterior descending artery, more frequent achievement of complete myocardial revascularization and a lower value of the residual SYNTAX index with the implantation of a smaller number of stents during the index intervention. In the recessive model (TT + TC/CC), the presence of the minor homozygous CC genotype increased the odds of developing periprocedural AKI by 7.2 times (OR 7.200; 95% CI [1.827–28.379], p = 0.011). Five years after the index PCI, patients with the minor C allele had worse renal function than those with the T allele (GFR ≤ 60 ml/min/1.73 m 2 in 19%, 36%, and 40% of patients in the groups with the TT, TC, and CC genotypes, respectively, p = 0.04). Aim. To study the association of the T1565C (rs5918) polymorphism in the ITGB3 gene with the characteristics of interventions, periprocedural complications and long-term prognosis of patients after elective endovascular myocardial revascularization. Methods . Polymorphic variants of the single nucleotide polymorphism T1565C (rs5918) in the ITGB3 gene were identified in 364 patients undergoing elective PCI. We studied the characteristics of coronary artery disease and the interventions performed, and also assessed the frequency of acute complications, late (5-year) adverse events, and the dynamics of renal function in the acute and late periods in groups of patients with different genotypes of the rs5918 polymorphism in the ITGB3 gene. Contingency tables and odds ratio (OR) calculations were used to assess the association of this polymorphism with endpoints. Results . The minor allele 1565C and the 1565CC of the polymorphism T1565C (rs5918) in the ITGB3 gene genotype are associated with more frequent hemodynamically significant stenosis of the left main coronary artery (4.4, 6.9 and 30% in the TT, TC and CC groups, respectively, p = 0.003) and the anterior descending artery (79, 66.7 and 100% in the TT, TC and CC groups, respectively, p = 0.01), more frequent achievement of complete myocardial revascularization (54.4, 70.6, 70% in the TT, TC and CC groups, respectively, p = 0.01) and a lower residual SYNTAX index (4.1 ± 6.7 (0–43.5); 2.9 ± 6.2 (0–28.5) and 2.4 ± 4.6 (0–14) in the TT, TC and CC groups, respectively, p = 0.02) with implantation of a smaller number of stents. In addition, an association was found between the minor 1565CC genotype with acute periprocedural kidney injury (OR 7.200; 95% CI [1.827–28.379], p = 0.011) and deterioration of renal function 5 years after index PCI (SCF ≤ 60 ml/min/1.73 m 2 in 19, 36 and 40% in the TT, TC and CC groups, respectively, p = 0.04). Conclusion . Under conditions of dual antiplatelet therapy, selected taking into account the residual platelet reactivity according to the aggregogram data, no association was found between the T1565C (rs5918) polymorphism in the ITGB3 gene and acute periprocedural myocardial injury and long-term cardiovascular complications. Polymorphism rs5918 in the ITGB3 gene is associated with acute periprocedural kidney injury and decreased renal function in the late period.
- Open Access
DNA methylation alterations in MIR10B , MIR21 , MIR100 , MIR127 and MIR143 genes associated with advanced carotid artery atherosclerosis: a targeted bisulfite sequencing study of vascular tissues and peripheral blood
DNA methylation is a key epigenetic mechanism regulating the expression of genes involved in numerous developmental and pathological processes. However, the contribution of DNA methylation of microRNA genes to atherosclerosis remains poorly understood. In this study, we profiled DNA methylation patterns of both the regulatory elements and gene bodies of five microRNA genes ( MIR10B , MIR21 , MIR100 , MIR127, and MIR143 ) in vascular tissues and paired peripheral blood cells (PBC) of 92 patients with advanced carotid atherosclerosis and 32 PBC of control participants by targeted bisulfite sequencing. We identified distinct tissue-specific DNA methylation patterns for all five microRNA genes in patients with advanced carotid atherosclerosis. The regulatory regions of MIR10B , MIR127 , and MIR100 were moderately hypomethylated in carotid atherosclerotic plaques compared with intact vascular tissues. We further integrated our findings with lab-internal and publicly available epigenome-wide methylation datasets and evaluated the influence of vascular and blood cell composition using computational deconvolution approaches. After adjustment for cellular heterogeneity in vascular tissues, DNA methylation at CpG sites in MIR100 and MIR127 remained independently associated with atherosclerosis. Increased DNA methylation at a single CpG site (chr11:122025143, GRCh37/hg19) located within the MIR100 E-box region was associated with metabolic syndrome. Moreover, DNA methylation levels of MIR10B , MIR21 , and MIR127 in atherosclerotic plaques were linked with indicators of histological instability and history of acute cerebrovascular events. In peripheral blood, we observed moderate hypomethylation of the regulatory regions of MIR10B , MIR21 , and the MIR100 E-box region in patients compared with the control group. However, only the MIR10B remained robust against blood cell composition. In blood, MIR10B and MIR143 methylation correlated with lipid metabolism and carotid stenosis, while the MIR21 CpG island showed strong blood-plaque concordance, confirming its potential as a surrogate biomarker. Overall, advanced carotid atherosclerosis is characterized by specific tissue-altering DNA methylation patterns of microRNA genes, where alterations mainly occur in the regulatory regions, predominantly featuring hypomethylation. The results underscore the complex, cell-and tissue-specific nature of DNA methylation of microRNA genes in both the regulatory elements and gene bodies in vascular tissue and blood, highlighting the critical need to decipher these intricate epigenetic landscapes to identify reliable, robust biomarkers for assessing plaque instability and cardiovascular risk.
Open AccessDNA methylation alterations in MIR10B , MIR21 , MIR100 , MIR127 and MIR143 genes associated with advanced carotid artery atherosclerosis: a targeted bisulfite sequencing study of vascular tissues and peripheral blood
DNA methylation is a key epigenetic mechanism regulating the expression of genes involved in numerous developmental and pathological processes. However, the contribution of DNA methylation of microRNA genes to atherosclerosis remains poorly understood. In this study, we profiled DNA methylation patterns of both the regulatory elements and gene bodies of five microRNA genes ( MIR10B , MIR21 , MIR100 , MIR127, and MIR143 ) in vascular tissues and paired peripheral blood cells (PBC) of 92 patients with advanced carotid atherosclerosis and 32 PBC of control participants by targeted bisulfite sequencing. We identified distinct tissue-specific DNA methylation patterns for all five microRNA genes in patients with advanced carotid atherosclerosis. The regulatory regions of MIR10B , MIR127 , and MIR100 were moderately hypomethylated in carotid atherosclerotic plaques compared with intact vascular tissues. We further integrated our findings with lab-internal and publicly available epigenome-wide methylation datasets and evaluated the influence of vascular and blood cell composition using computational deconvolution approaches. After adjustment for cellular heterogeneity in vascular tissues, DNA methylation at CpG sites in MIR100 and MIR127 remained independently associated with atherosclerosis. Increased DNA methylation at a single CpG site (chr11:122025143, GRCh37/hg19) located within the MIR100 E-box region was associated with metabolic syndrome. Moreover, DNA methylation levels of MIR10B , MIR21 , and MIR127 in atherosclerotic plaques were linked with indicators of histological instability and history of acute cerebrovascular events. In peripheral blood, we observed moderate hypomethylation of the regulatory regions of MIR10B , MIR21 , and the MIR100 E-box region in patients compared with the control group. However, only the MIR10B remained robust against blood cell composition. In blood, MIR10B and MIR143 methylation correlated with lipid metabolism and carotid stenosis, while the MIR21 CpG island showed strong blood-plaque concordance, confirming its potential as a surrogate biomarker. Overall, advanced carotid atherosclerosis is characterized by specific tissue-altering DNA methylation patterns of microRNA genes, where alterations mainly occur in the regulatory regions, predominantly featuring hypomethylation. The results underscore the complex, cell-and tissue-specific nature of DNA methylation of microRNA genes in both the regulatory elements and gene bodies in vascular tissue and blood, highlighting the critical need to decipher these intricate epigenetic landscapes to identify reliable, robust biomarkers for assessing plaque instability and cardiovascular risk.
- Open Access
- 9 July 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 41 (2) , 176-183
Association of the T1565C (rs5918) polymorphism of the ITGB3 gene with clinical characteristics, anatomical features and long-term adverse events in patients with chronic coronary artery disease after elective endovascular coronary interventions
Background . The T1565C (dbSNP ID: rs5918 ) polymorphism of the integrin gene ( ITGB3 ) is a risk factor for many diseases such as coronary heart disease (CHD), venous thrombosis, and oncology. The minor allele C is known to alter aspirin sensitivity and increase platelet aggregation, which may affect the incidence of cardiovascular complications after elective percutaneous coronary interventions (PCI). Aim : To study the association of the T1565C ( rs5918 ) polymorphism of the ITGB3 gene with clinical characteristics, anatomical features and long-term adverse events after elective PCI in patients with chronic CHD. Material and methods . The study included 364 patients with chronic CHD from a registry of elective PCI performed at the Research Institute of Cardiology of the Tomsk National Research Medical Center from 2010 to 2017. The association of polymorphic variants of rs5918 of the ITGB3 gene with long-term (5-year) adverse events was assessed using genotype frequency analysis and odds ratio (OR). Adverse events included death from cardiovascular and other causes, myocardial infarction (MI), stroke (CVA), and concomitant oncological diseases. Results . The genotype frequencies were: TT – 69.2%, TC – 28%, CC – 2.8%. The frequencies of T and C alleles were 83.2% and 16.8%. The presence of the T allele was associated with concomitant carbohydrate metabolism disorders in patients (OR = 1.502; CI [1.005–2.247]; S = 0.205; p = 0.047). The Charlson comorbidity index was higher in the group of carriers of the minor homozygous CC genotype compared to carriers of the T allele ( TC + TT groups) (Me ( Q1 – Q3 ); 4(3–5) vs 3(2–4), respectively, p = 0.025). No association was found between the rs5918 polymorphism of the ITGB3 gene and late adverse cardiovascular events and death from all causes. In the presence of the minor homozygous CC genotype, the chances of concomitant oncological diseases significantly increase (OR = 5.750; CI [1.359–24.335], S = 0.736, p = 0.035). Conclusion . The rs5918 polymorphism of the ITGB3 gene is associated with phenotype-specific characteristics of patients with chronic coronary artery disease who are eligible for elective PCI. These characteristics include varying degrees of comorbidity (as measured by the Charlson index), the frequency of carbohydrate metabolism disorders and cancer, as well as the severity and location of coronary lesions, which may impact the completeness of revascularization and the long-term prognosis of these patients.
- 9 July 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 41 (2) , 176-183
Open AccessAssociation of the T1565C (rs5918) polymorphism of the ITGB3 gene with clinical characteristics, anatomical features and long-term adverse events in patients with chronic coronary artery disease after elective endovascular coronary interventions
Background . The T1565C (dbSNP ID: rs5918 ) polymorphism of the integrin gene ( ITGB3 ) is a risk factor for many diseases such as coronary heart disease (CHD), venous thrombosis, and oncology. The minor allele C is known to alter aspirin sensitivity and increase platelet aggregation, which may affect the incidence of cardiovascular complications after elective percutaneous coronary interventions (PCI). Aim : To study the association of the T1565C ( rs5918 ) polymorphism of the ITGB3 gene with clinical characteristics, anatomical features and long-term adverse events after elective PCI in patients with chronic CHD. Material and methods . The study included 364 patients with chronic CHD from a registry of elective PCI performed at the Research Institute of Cardiology of the Tomsk National Research Medical Center from 2010 to 2017. The association of polymorphic variants of rs5918 of the ITGB3 gene with long-term (5-year) adverse events was assessed using genotype frequency analysis and odds ratio (OR). Adverse events included death from cardiovascular and other causes, myocardial infarction (MI), stroke (CVA), and concomitant oncological diseases. Results . The genotype frequencies were: TT – 69.2%, TC – 28%, CC – 2.8%. The frequencies of T and C alleles were 83.2% and 16.8%. The presence of the T allele was associated with concomitant carbohydrate metabolism disorders in patients (OR = 1.502; CI [1.005–2.247]; S = 0.205; p = 0.047). The Charlson comorbidity index was higher in the group of carriers of the minor homozygous CC genotype compared to carriers of the T allele ( TC + TT groups) (Me ( Q1 – Q3 ); 4(3–5) vs 3(2–4), respectively, p = 0.025). No association was found between the rs5918 polymorphism of the ITGB3 gene and late adverse cardiovascular events and death from all causes. In the presence of the minor homozygous CC genotype, the chances of concomitant oncological diseases significantly increase (OR = 5.750; CI [1.359–24.335], S = 0.736, p = 0.035). Conclusion . The rs5918 polymorphism of the ITGB3 gene is associated with phenotype-specific characteristics of patients with chronic coronary artery disease who are eligible for elective PCI. These characteristics include varying degrees of comorbidity (as measured by the Charlson index), the frequency of carbohydrate metabolism disorders and cancer, as well as the severity and location of coronary lesions, which may impact the completeness of revascularization and the long-term prognosis of these patients.
- 9 July 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 41 (2)
Systolic blood pressure time in the target range after renal denervation: relationship with the neurohormonal profile of patients with resistant hypertension
Introduction . Systolic blood pressure (SBP) time in target range (TTR) is a predictor of cardiovascular outcomes. However, data on long-term TTR after renal denervation (RDN) and its association with neuroendocrine parameters in patients with resistant hypertension (RHTN) are lacking. Aim : To assess the association between SBP time in the target range after RDN, based on over 3 years of follow-up, and the neurohormonal profile indicators in patients with RHTN. Material and Methods . Data from 89 patients with RHTN who completed ≥ 3 years of follow-up after RDN (median 5 years, range 3–9 years) from studies NCT01499810 and NCT02667912 were analyzed. Standard examination, including 24-hour ambulatory blood pressure (BP) monitoring, was performed. A biomarker panel of neurohormonal parameters (renin, angiotensin II, aldosterone, NT-proBNP, BNP, metanephrines and normetanephrines) was studied by ELISA; erythrocyte membrane beta-adrenoreactivity (β-AR) was measured using the β-AR-AGAT kit. Results . After RDN, a significant reduction in clinical and 24-hour BP was observed ( p < 0.01 for both). Mean TTR reached 29%. The frequency of TTR < 25% was 46%; 25–49% – 26%; ≥ 50% – 28%. Patients with TTR ≥ 50% had not only initially higher levels of metanephrines, normetanephrines and natriuretic peptides ( p < 0.05), but also a significant reduction in these markers after RDN, more pronounced than in other groups ( p < 0.05). The TTR ≥ 50% group also had higher baseline aldosterone levels ( p = 0.022) and lower β-AR values ( p = 0.12), with a more pronounced increase in β-AR ( p = 0.03) and a decrease in 24-hour SBP variability ( p = 0.02) after RDN. In patients with a decrease in catecholamines after RDN compared to those with an increase, mean TTR was 7 times higher (50% vs. 7.14%, respectively, p = 0.016). Conclusion . The association between the duration systolic blood pressure (SBP) time in target range after renal denervation and the baseline state of sympathoadrenal activity in patients with resistant hypertension suggests that correction of the neurohormonal profile may be one of the key mechanisms of the therapeutic action of this intervention.
- 9 July 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 41 (2)
Systolic blood pressure time in the target range after renal denervation: relationship with the neurohormonal profile of patients with resistant hypertension
Introduction . Systolic blood pressure (SBP) time in target range (TTR) is a predictor of cardiovascular outcomes. However, data on long-term TTR after renal denervation (RDN) and its association with neuroendocrine parameters in patients with resistant hypertension (RHTN) are lacking. Aim : To assess the association between SBP time in the target range after RDN, based on over 3 years of follow-up, and the neurohormonal profile indicators in patients with RHTN. Material and Methods . Data from 89 patients with RHTN who completed ≥ 3 years of follow-up after RDN (median 5 years, range 3–9 years) from studies NCT01499810 and NCT02667912 were analyzed. Standard examination, including 24-hour ambulatory blood pressure (BP) monitoring, was performed. A biomarker panel of neurohormonal parameters (renin, angiotensin II, aldosterone, NT-proBNP, BNP, metanephrines and normetanephrines) was studied by ELISA; erythrocyte membrane beta-adrenoreactivity (β-AR) was measured using the β-AR-AGAT kit. Results . After RDN, a significant reduction in clinical and 24-hour BP was observed ( p < 0.01 for both). Mean TTR reached 29%. The frequency of TTR < 25% was 46%; 25–49% – 26%; ≥ 50% – 28%. Patients with TTR ≥ 50% had not only initially higher levels of metanephrines, normetanephrines and natriuretic peptides ( p < 0.05), but also a significant reduction in these markers after RDN, more pronounced than in other groups ( p < 0.05). The TTR ≥ 50% group also had higher baseline aldosterone levels ( p = 0.022) and lower β-AR values ( p = 0.12), with a more pronounced increase in β-AR ( p = 0.03) and a decrease in 24-hour SBP variability ( p = 0.02) after RDN. In patients with a decrease in catecholamines after RDN compared to those with an increase, mean TTR was 7 times higher (50% vs. 7.14%, respectively, p = 0.016). Conclusion . The association between the duration systolic blood pressure (SBP) time in target range after renal denervation and the baseline state of sympathoadrenal activity in patients with resistant hypertension suggests that correction of the neurohormonal profile may be one of the key mechanisms of the therapeutic action of this intervention.
- 12 January 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (4)
Association of mitochondrial DNA C7028T, G3010A, G9055A polymorphisms and the severity of chronic heart failure of ischemic genesis
Introduction. Common mitochondrial DNA (mtDNA) polymorphisms can affect the intensity of cellular respiration and the production of reactive oxygen species. Excessive amounts of reactive oxygen species lead to oxidative stress, which contributes to the development of multifactorial diseases. It can be expected that mtDNA polymorphisms can act as candidate risk loci for the development or progression of cardiovascular pathology. Aim: To evaluate the association of mtDNA polymorphisms C7028T, G3010A and G9055A with the severity of chronic heart failure (CHF) in patients with ischemic heart disease. Material and Methods . The sample included 97 patients aged 63 (58; 68) years. A history of myocardial infarction was diagnosed in 74 (76.3%) patients. Standard clinical and instrumental research methods were performed. The mtDNA polymorphisms were determined using polymerase chain reaction followed by restriction fragment length polymorphism analysis. Results . It was found that among patients with a moderately reduced ejection fraction, the 7028T allele was found 2 times more often than among patients with preserved and reduced ejection fraction (EF) (78.9% versus 34.3% and 34.9%, p = 0.002). In patients with low EF and right atrial dilation, the frequency of the 7028C allele was 8 (44.4%), the 7028T allele – 10 (55.6%); without dilation – 20 (80.0%) and 5 (20.0%) (p = 0.024). There was no association between the G3010A polymorphism and parameters characterizing the severity of CHF. However, the frequency of 3010A substitution was lower among patients requiring diuretic therapy than among those not taking diuretics (8.6% vs. 30.8%, p = 0.005). Only 3 patients (3.1%) were identified with the 9055A allele. Conclusion . Among patients with CHF of ischemic genesis, an association of mtDNA C7028T polymorphism with a heart failure phenotype with a moderately reduced left ventricular EF and in group with low EF with right atrial dilation was revealed. The mtDNA G3010A polymorphism was associated with a diuretic prescription.
- 12 January 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (4)
Association of mitochondrial DNA C7028T, G3010A, G9055A polymorphisms and the severity of chronic heart failure of ischemic genesis
Introduction. Common mitochondrial DNA (mtDNA) polymorphisms can affect the intensity of cellular respiration and the production of reactive oxygen species. Excessive amounts of reactive oxygen species lead to oxidative stress, which contributes to the development of multifactorial diseases. It can be expected that mtDNA polymorphisms can act as candidate risk loci for the development or progression of cardiovascular pathology. Aim: To evaluate the association of mtDNA polymorphisms C7028T, G3010A and G9055A with the severity of chronic heart failure (CHF) in patients with ischemic heart disease. Material and Methods . The sample included 97 patients aged 63 (58; 68) years. A history of myocardial infarction was diagnosed in 74 (76.3%) patients. Standard clinical and instrumental research methods were performed. The mtDNA polymorphisms were determined using polymerase chain reaction followed by restriction fragment length polymorphism analysis. Results . It was found that among patients with a moderately reduced ejection fraction, the 7028T allele was found 2 times more often than among patients with preserved and reduced ejection fraction (EF) (78.9% versus 34.3% and 34.9%, p = 0.002). In patients with low EF and right atrial dilation, the frequency of the 7028C allele was 8 (44.4%), the 7028T allele – 10 (55.6%); without dilation – 20 (80.0%) and 5 (20.0%) (p = 0.024). There was no association between the G3010A polymorphism and parameters characterizing the severity of CHF. However, the frequency of 3010A substitution was lower among patients requiring diuretic therapy than among those not taking diuretics (8.6% vs. 30.8%, p = 0.005). Only 3 patients (3.1%) were identified with the 9055A allele. Conclusion . Among patients with CHF of ischemic genesis, an association of mtDNA C7028T polymorphism with a heart failure phenotype with a moderately reduced left ventricular EF and in group with low EF with right atrial dilation was revealed. The mtDNA G3010A polymorphism was associated with a diuretic prescription.
- Open Access
- 26 December 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 24 (4) , 31-39
Genetic and functional features of peripheral blood leukocyte mitochondria in patients with coronary heart disease and high risk of sudden cardiac death
Aim. To assess the relationship between the respiration of mitochondria of peripheral blood leukocytes and mitochondrial DNA (mtDNA) polymorphism in patients with coronary heart disease (CHD) depending on the risk of developing sudden cardiac death (SCD). Materials and methods. We formed two groups of patients: the main group – patients with CHD and the high risk of SCD ( n = 107); the comparison group – patients with stable course of CHD without the risk of SCD ( n = 50). Using methods of high-throughput sequencing, we determined patients’ haplogroup and carriage of mtDNA polymorphisms A2706G, G3010A and G9055A. The respiratory activity of isolated mitochondria from peripheral blood leukocytes was assessed by amperometric method using NADand FAD-dependent oxidation substrates. Results. In both studied groups, H, U, and J haplogroups were predominant (74.5% and 92.5%, respectively, for the main group and the comparison group). There were more minor haplogroups in the main group than in the comparison group. The frequencies of occurrence of polymorphisms A2706G, G3010A, and G9055A did not significantly differ between the groups. In the main group, carriage of the A2706G polymorphism was associated with a decrease in the respiratory control ratio (RC) in FAD-dependent respiration ( p = 0.05), and in the comparison group it was associated with a decrease in oxygen consumption rate (OCR) in the V4 metabolic state in both NADand FAD-dependent respiration ( p = 0.002 and p = 0.008, respectively) without changing in RC. In the main group, carriage of the G9055A polymorphism was associated with a decrease in OCR in the V3 metabolic state ( p = 0.037) in FAD-dependent respiration. For the G3010A polymorphism, no association with mitochondrial respiration was found in the studied groups. Conclusion. In patients with CHD, regardless of the risk of SCD, the frequencies of haplogroups H, U, and J and mtDNA polymorphisms A2706G, G3010A, and G9055A do not differ significantly. In patients with high risk of SCD, carriage of the A2706G polymorphism is associated with a decrease in RC in FAD-dependent respiration, and the G9055A polymorphism is associated with a decrease in OCR in V3 during FAD-dependent respiration.
- 26 December 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 24 (4) , 31-39
Open AccessGenetic and functional features of peripheral blood leukocyte mitochondria in patients with coronary heart disease and high risk of sudden cardiac death
Aim. To assess the relationship between the respiration of mitochondria of peripheral blood leukocytes and mitochondrial DNA (mtDNA) polymorphism in patients with coronary heart disease (CHD) depending on the risk of developing sudden cardiac death (SCD). Materials and methods. We formed two groups of patients: the main group – patients with CHD and the high risk of SCD ( n = 107); the comparison group – patients with stable course of CHD without the risk of SCD ( n = 50). Using methods of high-throughput sequencing, we determined patients’ haplogroup and carriage of mtDNA polymorphisms A2706G, G3010A and G9055A. The respiratory activity of isolated mitochondria from peripheral blood leukocytes was assessed by amperometric method using NADand FAD-dependent oxidation substrates. Results. In both studied groups, H, U, and J haplogroups were predominant (74.5% and 92.5%, respectively, for the main group and the comparison group). There were more minor haplogroups in the main group than in the comparison group. The frequencies of occurrence of polymorphisms A2706G, G3010A, and G9055A did not significantly differ between the groups. In the main group, carriage of the A2706G polymorphism was associated with a decrease in the respiratory control ratio (RC) in FAD-dependent respiration ( p = 0.05), and in the comparison group it was associated with a decrease in oxygen consumption rate (OCR) in the V4 metabolic state in both NADand FAD-dependent respiration ( p = 0.002 and p = 0.008, respectively) without changing in RC. In the main group, carriage of the G9055A polymorphism was associated with a decrease in OCR in the V3 metabolic state ( p = 0.037) in FAD-dependent respiration. For the G3010A polymorphism, no association with mitochondrial respiration was found in the studied groups. Conclusion. In patients with CHD, regardless of the risk of SCD, the frequencies of haplogroups H, U, and J and mtDNA polymorphisms A2706G, G3010A, and G9055A do not differ significantly. In patients with high risk of SCD, carriage of the A2706G polymorphism is associated with a decrease in RC in FAD-dependent respiration, and the G9055A polymorphism is associated with a decrease in OCR in V3 during FAD-dependent respiration.
- Open Access
- 15 October 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 24 (3) , 97-106
Effects of nitric oxide on sympathoadrenal system activity in patients with ischemic heart disease in coronary artery bypass grafting
Aim. To investigate changes in laboratory parameters of sympathoadrenal system activity and β-adrenergic receptor reactivity of erythrocyte membranes (β-ARMe) in ischemic heart disease (IHD) patients with clinical forms of arterial hypertension of high cardiovascular risk during coronary artery bypass grafting with anesthetic management including nitric oxide.Materials and мethods. In this randomized study with parallel distribution, 36 patients (male – 66.7%; average age – 68 [63; 70] years) with IHD and clinical forms of arterial hypertension of high cardiovascular risk were enrolled. According to the indications, all patients underwent elective coronary artery bypass grafting (CABG) using extracorporeal circulation (ECC). Patients were randomly divided into the main and control groups. Patients of the main group intraoperatively received NO at the concentration of 80 ppm first in the breathing circuit and then in the ECC circuit. Patients of the control group underwent CABG with standard mechanical lung ventilation and ECC. Before connecting to the ECC, at the end of ECC, and 1 day after CABG, all patients underwent clinical, laboratory, and instrumental tests in accordance with the clinical standards, β-ARMe was assessed, and the concentration of norepinephrine and epinephrine in the blood plasma was determined by ELISA.Results. At the presurgical stage and 1 day after CABG, the groups did not differ in clinical and biochemical parameters. At the presurgical stage, the median values of β-ARMe in the main and control groups slightly exceeded the upper limits of normal and did not differ significantly. CABG was not accompanied by changes in β-ARMe in the control group. Intrasurgical NO donation also did not affect the level of β-ARMe. One day after CABG, neither intergroup differences in β-ARMe nor significant changes in the parameter during follow-up in each group were noted. In both control and main groups, a significant increase in the levels of epinephrine and norepinephrine was detected 1 day after CABG compared to the baseline level. At the same time, there were no intergroup differences in the level of catecholamines either before ECC or 1 day after CABG.Conclusion. In cardiac surgery with extracorporeal circulation, the use of NO for the purpose of organ protection does not affect the level of β-ARMe and changes in the mediator response of the sympathetic system to stress in patients with IHD and clinical forms of hypertension of high cardiovascular risk.
- 15 October 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 24 (3) , 97-106
Open AccessEffects of nitric oxide on sympathoadrenal system activity in patients with ischemic heart disease in coronary artery bypass grafting
Aim. To investigate changes in laboratory parameters of sympathoadrenal system activity and β-adrenergic receptor reactivity of erythrocyte membranes (β-ARMe) in ischemic heart disease (IHD) patients with clinical forms of arterial hypertension of high cardiovascular risk during coronary artery bypass grafting with anesthetic management including nitric oxide.Materials and мethods. In this randomized study with parallel distribution, 36 patients (male – 66.7%; average age – 68 [63; 70] years) with IHD and clinical forms of arterial hypertension of high cardiovascular risk were enrolled. According to the indications, all patients underwent elective coronary artery bypass grafting (CABG) using extracorporeal circulation (ECC). Patients were randomly divided into the main and control groups. Patients of the main group intraoperatively received NO at the concentration of 80 ppm first in the breathing circuit and then in the ECC circuit. Patients of the control group underwent CABG with standard mechanical lung ventilation and ECC. Before connecting to the ECC, at the end of ECC, and 1 day after CABG, all patients underwent clinical, laboratory, and instrumental tests in accordance with the clinical standards, β-ARMe was assessed, and the concentration of norepinephrine and epinephrine in the blood plasma was determined by ELISA.Results. At the presurgical stage and 1 day after CABG, the groups did not differ in clinical and biochemical parameters. At the presurgical stage, the median values of β-ARMe in the main and control groups slightly exceeded the upper limits of normal and did not differ significantly. CABG was not accompanied by changes in β-ARMe in the control group. Intrasurgical NO donation also did not affect the level of β-ARMe. One day after CABG, neither intergroup differences in β-ARMe nor significant changes in the parameter during follow-up in each group were noted. In both control and main groups, a significant increase in the levels of epinephrine and norepinephrine was detected 1 day after CABG compared to the baseline level. At the same time, there were no intergroup differences in the level of catecholamines either before ECC or 1 day after CABG.Conclusion. In cardiac surgery with extracorporeal circulation, the use of NO for the purpose of organ protection does not affect the level of β-ARMe and changes in the mediator response of the sympathetic system to stress in patients with IHD and clinical forms of hypertension of high cardiovascular risk.